Transforming Specialty Medication Access: Spotlight on Allergy, Oncology, and Dermatology

In the ever-changing specialty medication space, ensuring timely access to care is critical. However, the typical process for enrolling patients in specialty medication programs has been fraught with challenges, including cumbersome paperwork, non-digital workflows, and labor-intensive approvals or consent collection. These challenges reduce therapy initiation and adherence, negatively impacting patient health while decreasing conversions and revenue for manufacturers.

At RxLightning, we are revolutionizing this process with our web-based solution, making it easier for patients to receive the medications they need, at lightning speed. Below, we take a closer look at how our platform is making a difference across three key therapeutic areas: allergy/immunology, oncology, and dermatology.

How Digital Enrollment Streamlines Medication Access

Specialty medications often require complex enrollment processes. This is especially true for allergy, dermatology, and oncology, where payers, providers, manufacturers, and pharmacies must be aligned on a care plan. But complexity should not impede speed-to-therapy. RxLightning has created a robust technology solution that improves access, affordability, and engagement for patients needing allergy, dermatology, and oncology medications.

By digitizing manufacturer and hub enrollment forms, provider teams can easily find and submit paperwork without a printer or fax machine. Instead of going to each manufacturer’s website, stakeholders can login to one portal and leverage a consistent workflow to complete any form. These embedded forms have required fields and auto-populate patient information sourced from provider systems. This dramatically increases the speed at which a form can be completed by the care team and received by the manufacturer, hub, or pharmacy. Further, integrated prior authorization and benefit check capabilities reduce the time needed to confirm coverage and approve a patient therapy regimen. With RxLightning, each step in the patient access journey is digital and transparent, allowing stakeholders to support an accelerated path to care.

Affordability is also essential when thinking about patient adherence, and RxLightning provides price transparency, patient assistance program (PAP) forms, copay discounts, and foundation options – all in an effort to reduce the cost of patient care. With robust options embedded within one tool, patients and providers can agree on the most effective care plan – one that the patient can afford.

Allergy, dermatology, and oncology therapies often require patient consent prior to medication dispensation or the introduction of support services. With multi-channel consent collection processes, manufacturers and hubs are enabled with opt-ins and can support patients throughout their care journey, significantly increasing the likelihood of therapy initiation and ongoing adherence. Manufacturers in these areas can maximize efficiency with digital form intake, benefit check capabilities, affordability options, and consent collection, all in an effort to improve the patient experience.

The specialty medications submitted most frequently within RxLightning’s solution include:

*List includes sponsored and non-sponsored programs within the RxLightning platform

Supporting Manufacturers to Increase Digital Enrollment Volumes

The RxLightning platform is medication-agnostic, meaning providers can leverage a repeatable workflow to submit enrollments from any manufacturer. However, with branding options and website redirects, custom question sets, and tailored communications, providers and patients can initiate and complete the onboarding experience as the manufacturer intended.

Allergy/immunology, dermatology, and oncology are among the top specialties that RxLightning supports, with thousands of enrollments flowing through our tool each month within these categories.

• Oncology, due to the significant medication costs and complexity in enrollment, is an area where reduction in enrollment burden and time can meaningfully impact patient health. By removing time-consuming, manual, error-prone processes, our manufacturer partners – and their providers – see significant improvements in time-to-submit and medication conversions. Many of our oncology partners see significant increases in patient consent collection – upwards of 90% – enabling hub outreach and ongoing patient engagement.
• Additionally, brand.com website redirects and branded portals are common in the allergy and dermatology space to create a seamless enrollment experience for end-users – without having to re-train users on a new portal. By using the RxLightning solution, one provider was able to complete 6 enrollments in under 25 minutes, something that previously took multiple hours.

RxLightning is transforming the way specialty medications are accessed, making a difference in the lives of patients across various therapeutic areas. By delivering innovative technology to provider workflows, RxLightning is not only reducing administrative burden, but improving patient outcomes. We work with manufacturers – in any specialty – to create custom enrollment workflows for high-value medications. Please reach out today if you would like to learn more about partnership opportunities.